staceywhite, Author at European Medical Journal - Page 137 of 194

Drug Trough Levels and Antidrug Antibodies in Nonselected Ankylosing Spondylitis Patients Using Subcutaneous Anti-TNF Drugs

Immunisation of biological drugs can result in reduced efficacy of treatment and an increased risk of adverse effects.

Editor’s Pick: Why do Diseases Start One Sided? Clues From HLA-B27 Acute Anterior Uveitis

Uveitis is an inflammatory disease with significant disease burden, as it causes ≤10% of legal blindness in the USA.

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

In this review, the role of the organic osmolytes taurine, betaine, myo-inositol, and sorbitol in skeletal muscles in general, and in myositis in…

Sleep Disorders in Fibromyalgia Patients: The Role of Autonomic Nervous System Dysfunction

Fibromyalgia is characterised by chronic musculoskeletal pain, autonomic nervous system dysfunction, and disturbed sleep.

Serum Urate as a Surrogate Endpoint for Flares in People with Gout: A Systematic Review and Meta-Regression Analysis

The OMERACT gout group has, for several years, been working towards a model for evaluating a biomarker as surrogate endpoint for clinically relevant outcomes.

Advances in Epigenetics and Integration of Omics in Lupus

Systemic lupus erythematosus is a chronic, multi-organ disease that predominantly affects young women of childbearing age.

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

Rheumatoid arthritis, the most frequent chronic inflammatory autoimmune disease, can lead to pain, bone and articular destruction, and limb…

Weight Loss for Overweight and Obese Individuals with Gout: A Systematic Review of Longitudinal Studies

It has been estimated that almost half of gout patients in Europe are obese.

Vitamin D Deficiency and Chronic Widespread Pain

Vitamin D acts as a steroid hormone possessing important functions in calcium and phosphorus balance and bone health.

Rheumatoid Arthritis and Polymyalgia Rheumatica After Immune Checkpoint Inhibitor Treatment

Immune checkpoint inhibitors targeting cytotoxic T-lymphocyte–associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have demonstrated…